Kai Andersen

Med-Storm Innovation (Norway)

Papers

1

Total Citations

34

H-Index

1

About

Kai Andersen is a clinical geneticist whose work has significantly advanced the understanding of Marfan syndrome (MFS), a complex monogenic connective tissue disorder. His research focuses on the critical challenge of correlating genotype with phenotype in hereditary diseases, particularly how specific mutations in the *FBN1* gene translate into the full spectrum of clinical features. In his landmark 2007 study, Andersen conducted a comprehensive analysis of 44 unrelated Norwegian patients, systematically searching for correlations between *FBN1* genotype and the complete Ghent phenotype. This work, which has garnered 34 citations, provided essential insights into the premise that predictive genetic testing can enable earlier prophylaxis and more effective clinical follow-up for at-risk individuals. By demonstrating the nuanced relationship between genetic variants and disease expression, Andersen’s contributions have helped refine diagnostic criteria and improve prognostic counseling for MFS patients. His research underscores the importance of integrating molecular genetics with clinical observation, paving the way for more personalized management strategies in monogenic disorders.

Research Focus

Key Achievements

1
H-Index
1
Papers
34
Total Citations
34
Avg Citations/Paper
🏆 Most Cited Paper
Search for correlations between <i>FBN1</i> genotype and complete Ghent phenotype in 44 unrelated Norwegian patients with Marfan syndrome
34 citations · 2007
📈 Most Prolific Year: 2007 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Med-Storm Innovation (Norway)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago